Merck (NYSE:MRK) agreed to acquire immunotherapy developer Harpoon Therapeutics (NASDAQ:HARP) for $23.00 per share in cash for ~$680M of total equity value, the companies confirmed Monday. Shares of ...
Ahead of CES, Corsair announced a trio of gaming mice ranging from $49.99~59.99, and fortunately for those pursuing an upgrade, it’s very likely that one of these rodents will grab you more than the ...